A further review of inhalation studies with cigarette smoke and lung cancer in experimental animals, including transgenic mice

Inhalation Toxicology

Volumn 22, Issue 12, 2010, Pages 974-983

  Coggins, C R E ^a  

^a Carson Watts Consulting   (United States)

Author keywords

Cigarettes; inhalation; laboratory animals; lung cancer; transgenic mice

Indexed keywords

CIGARETTE SMOKE;

A J MOUSE; AKR MOUSE; BAGG ALBINO MOUSE; C3H MOUSE; C57BL MOUSE; CANCER MODEL; CIGARETTE SMOKING; DBA MOUSE; ENVIRONMENTAL EXPOSURE; EXPERIMENTAL ANIMAL; INHALATION; LUNG CANCER; LUNG CARCINOGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SWISS WEBSTER MOUSE; TRANSGENIC MOUSE;

ADENOCARCINOMA; ADENOMA; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INHALATION EXPOSURE; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; RATS; REPRODUCIBILITY OF RESULTS; SMOKING; SPECIES SPECIFICITY;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 77957560928     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2010.501831     Document Type: Review

References (74)

1. Arteaga CL. 2006. EGF receptor mutations in lung cancer: from humans to mice and maybe back to humans. Cancer Cell 9:421-423.
2. Balansky R, D' Agostini F, Zannacchi P, De Flora S. 1992. Protection by N-acetylcysteine of the histopathological and cytogenetical damage produced by exposure of rats to cigarette smoke. Cancer Lett 64:123-131.
3. Balansky R, Ganchev G, Iltcheva M, Steele VE, De Flora S. 2009. Prenatal N-acetylcysteine prevents cigarette smoke-induced lung cancer in neonatal mice. Carcinogenesis 30:1398-1401.
4. Balansky R, Ganchev G, Iltcheva M, Steele VE, De Flora S. 2010. Prevention of cigarette smoke-induced lung tumors in mice by budesonide, phenethyl isothiocyanate, and N-acetylcysteine. Int J Cancer 126:1047-1054.
5. Balansky R, Ganchev G, Iltcheva M, Steele VE, D'Agostini F, De Flora S. 2007. Potent carcinogenicity of cigarette smoke in mice exposed early in life. Carcinogenesis 28:2236-2243.
6. Basyigit I, Tugay M, Dilioglugil MO, Yildiz F, Maral H, Sozubir S. 2007. Protective efects of N-acetylcysteine on peroxidative changes of the fetal rat lungs whose mothers were exposed to cigarette smoke. Hum Exp Toxicol 26:99-103.
7. Berger J, Wynder EL. 1994. Te correlation of epidemiological variables. J Clin Epidemiol 47:941-952.
8. Chen BT, Bechtold WE, Barr EB, Cheng YS, Mauderly JL, Cuddihy RG. 1989a. Comparison of cigarette smoke exposure atmospheres in diferent exposure and pufng modes. Inhal Toxicol 1:331-347.
9. Chen BT, Bechtold WE, Mauderly JL. 1992. Description and evaluation of a cigarette smoke generation system for inhalation studies. J Aerosol Med 5:19-30.
10. Chen BT, Weber RE, Yeh HC, Lundgren DL, Snipes MB, Mauderly JL. 1989b. Deposition of cigarette smoke particles in the rat. Fundam Appl Toxicol 13:429-438.
11. Coggins CR. 1998. A review of chronic inhalation studies with mainstream cigarette smoke in rats and mice. Toxicol Pathol 26:307-14; discussion 315.
12. Coggins C. 2000. Chronic inhalation studies with mainstream cigarette smoke in rats and mice. Toxicol Pathol 28:754.
13. Coggins CR. 2001. A review of chronic inhalation studies with mainstream cigarette smoke, in hamsters, dogs, and nonhuman primates. Toxicol Pathol 29:550-557.
14. Coggins CR. 2002. A minireview of chronic animal inhalation studies with mainstream cigarette smoke. Inhal Toxicol 14:991-1002.
15. Coggins CR. 2007. An updated review of inhalation studies with cigarette smoke in laboratory animals. Int J Toxicol 26:331-338.
16. Curtin GM, Higuchi MA, Ayres PH, Swauger JE, Mosberg AT. 2004. Lung tumorigenicity in A/J and rasH2 transgenic mice following mainstream tobacco smoke inhalation. Toxicol Sci 81:26-34.
17. D' Agostini F, Balansky R, Steele VE, Ganchev G, Pesce C, De Flora S. 2008. Preneoplastic and neoplastic lesions in the lung, liver and urinary tract of mice exposed to environmental cigarette smoke and UV light since birth. Int J Cancer 123:2497-2502.
18. D' Agostini F, Mastracci L, Izzotti A, Balansky R, Pennisi TM, Steele VE, De Flora S. 2009. Modulation by phenethyl isothiocyanate and budesonide of molecular and histopathologic alterations induced by environmental cigarette smoke in mice. Cancer Prevention Research 2:546-556.
19. De Flora S, Balansky RM, D'Agostini F, Izzotti A, Camoirano A, Bennicelli C, Zhang Z, Wang Y, Lubet RA, You M. 2003. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke. Cancer Res 63:793-800.
20. de Seranno S, Meuwissen R. 2010. Progress and applications of mouse models for human lung cancer. Eur Respir J 35:426-443.
21. FDA. 2009. U.S. Congress. Family smoking prevention and tobacco control act Section 911. Modifed risk tobacco products. H.R. 1256.
22. Fiala ES, Sohn OS, Wang CX, Seibert E, Tsurutani J, Dennis PA, El-Bayoumy K, Sodum RS, Desai D, Reinhardt J, Aliaga C. 2005. Induction of preneoplastic lung lesions in guinea pigs by cigarette smoke inhalation and their exacerbation by high dietary levels of vitamins C and E. Carcinogenesis 26:605-612.
23. Frame LT, Hart RW, Leakey JE. 1998. Caloric restriction as a mechanism mediating resistance to environmental disease. Environ Health Perspect 106 Suppl 1:313-324.
24. Gebel S, Gerstmayer B, Kuhl P, Borlak J, Meurrens K, Müller T. 2006. Te kinetics of transcriptomic changes induced by cigarette smoke in rat lungs reveals a specifc program of defense, infammation, and circadian clock gene expression. Toxicol Sci 93:422-431.
25. Gordon T, Bosland M. 2009. Strain-dependent diferences in susceptibility to lung cancer in inbred mice exposed to mainstream cigarette smoke. Cancer Lett 275:213-220.
26. Gori GB. 2009. US regulation of less risky cigarettes-a world frst. Regul Toxicol Pharmacol 55:247-248.
27. Hahn FF, Gigliotti AP, Hutt JA, March TH, Mauderly JL. 2007. A review of the histopathology of cigarette smoke-induced lung cancer in rats and mice. Int J Toxicol 26:307-313.
28. Hamm JT, Yee S, Rajendran N, Morrissey RL, Richter SJ, Misra M. 2007. Histological alterations in male A/J mice following nose-only exposure to tobacco smoke. Inhal Toxicol 19:405-418.
29. Hanahan D, Wagner EF, Palmiter RD. 2007. Te origins of oncomice: a history of the frst transgenic mice genetically engineered to develop cancer. Genes Dev 21:2258-2270.
30. Hart RW, Dixit R, Seng J, Turturro A, Leakey JE, Feuers R, Dufy P, Bufngton C, Cowan G, Lewis S, Pipkin J, Li SY 1999. Adaptive role of caloric intake on the degenerative disease processes. Toxicol Sci 52(2 Suppl):3-12.
31. Hatsukami DK, Joseph AM, Lesage M, Jensen J, Murphy SE, Pentel PR, Kotlyar M, Borgida E, Le C, Hecht SS. 2007. Developing the science base for reducing tobacco harm. Nicotine Tob Res 9 Suppl 4: S537-S553.
32. Hecht SS. 2005. Carcinogenicity studies of inhaled cigarette smoke in laboratory animals: old and new. Carcinogenesis 26:1488-1492.
33. Hutt JA, Vuillemenot BR, Barr EB, Grimes MJ, Hahn FF, Hobbs CH, March TH, Gigliotti AP, Seilkop SK, Finch GL, Mauderly JL, Belinsky SA. 2005. Life-span inhalation exposure to mainstream cigarette smoke induces lung cancer in B6C3F1 mice through genetic and epigenetic pathways. Carcinogenesis 26:1999-2009.
34. Institute of Medicine. 2001. Clearing the smoke. Assessing the science base for tobacco harm reduction. Washington, DC 20055: National Academy Press.
35. Izzotti A, Cartiglia C, Longobardi M, Bagnasco M, Merello A, You M, Lubet RA, De Flora S. 2004. Gene expression in the lung of p53 mutant mice exposed to cigarette smoke. Cancer Res 64:8566-8572.
36. Jacobson-Kram D. 2010. Cancer risk assessment approaches at the FDA/ CDER: Is the era of the 2-year bioassay drawing to a close? Toxicol Pathol 38:169-170.
37. Khuder SA, Mutgi AB. 2001. Efect of smoking cessation on major histologic types of lung cancer. Chest 120:1577-1583.
38. Kim Y, Chongviriyaphan N, Liu C, Russell RM, Wang XD. 2006a. Combined antioxidant (beta-carotene, alpha-tocopherol and ascorbic acid) supplementation increases the levels of lung retinoic acid and inhibits the activation of mitogen-activated protein kinase in the ferret lung cancer model. Carcinogenesis 27:1410-1419.
39. Kim Y, Lian F, Yeum KJ, Chongviriyaphan N, Choi SW, Russell RM, Wang XD. 2007. Te efects of combined antioxidant (beta-carotene, alphatocopherol and ascorbic acid) supplementation on antioxidant capacity, DNA singlestrand breaks and levels of insulin-like growth factor-1/IGF-binding protein 3 in the ferret model of lung cancer. Int J Cancer 120:1847-1854.
40. Kim Y, Liu XS, Liu C, Smith DE, Russell RM, Wang XD. 2006b. Induction of pulmonary neoplasia in the smoke-exposed ferret by 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone (NNK): a model for human lung cancer. Cancer Lett 234:209-219.
41. Li H, Kwak I, DeMayo FJ. 2005. Genetically engineered mouse models for lung cancer. Drug Discovery Today: Disease Models 2:35-40.
42. Life Sciences Research Ofce. 2007. Scientifc methods to evaluate potential reduced-risk tobacco products. Bethesda, MD: LSRO.
43. Long GG, Morton D, Peters T, Short B, Skydsgaard M. 2010. Alternative mouse models for carcinogenicity assessment: industry use and issues with pathology interpretation. Toxicol Pathol 38:43-50.
44. Lubet R, Wang Y, Zhang Z, You M. 2005. Mouse models incorporating alterations in the major tumor suppressor genes P53 and P16: their use in screening for potential carcinogens, developing further relevant mouse models, and screening for potential chemopreventive and chemotherapetutic agents. Exp Lung Res 31:117-133.
45. Lubet RA, Zhang Z, Wiseman RW, You M. 2000. Use of p53 transgenic mice in the development of cancer models for multiple purposes. Exp Lung Res 26:581-593.
46. Lynch D, Svoboda J, Putta S, Hofand HE, Chern WH, Hansen LA. 2007. Mouse skin models for carcinogenic hazard identifcation: utilities and challenges. Toxicol Pathol 35:853-864.
47. Marian C, O'Connor RJ, Djordjevic MV, Rees VW, Hatsukami DK, Shields PG. 2009. Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies. Cancer Epidemiol Biomarkers Prev 18:3305-3320.
48. Mauderly JL, Gigliotti AP, Barr EB, Bechtold WE, Belinsky SA, Hahn FF, Hobbs CA, March TH, Seilkop SK, Finch GL. 2004. Chronic inhalation exposure to mainstream cigarette smoke increases lung and nasal tumor incidence in rats. Toxicol Sci 81:280-292.
49. McGrath-Morrow S, Rangasamy T, Cho C, Sussan T, Neptune E, Wise R, Tuder RM, Biswal S. 2008. Impaired lung homeostasis in neonatal mice exposed to cigarette smoke. Am J Respir Cell Mol Biol 38:393-400.
50. Meckley D, Hayes JR, Van Kampen KR, Mosberg AT, Swauger JE. 2004. A respon-sive, sensitive, and reproducible dermal tumor promotion assay for the comparative evaluation of cigarette smoke condensates. Regul Toxicol Pharmacol 39:135-149.
51. Morton D, Alden CL, Roth AJ, Usui T. 2002. Te Tg rasH2 mouse in cancer haz-ard identifcation. Toxicol Pathol 30:139-146.
52. Murrelle EL, Coggins CRE, Gennings C, Carchman RA, Carter WH, Davies BD, Krauss MR, Lee PN, Schleef RR, Zedler BK, Heidbreder C. 2010a. Hypotheses and fundamental study design characteristics for evaluating potential reduced-risk tobacco products. Part I: Heuristic. Regul Toxicol Pharmacol 57:1-10.
53. Murrelle L, Coggins CR, Gennings C, Carchman RA, Lee PN, Zedler BK, Heidbreder C. 2010b. Further considerations on the evaluation of poten-tial reduced-risk tobacco products. Part II: Re-assessment of a heuristic using the CPS-II database. Regul Toxicol Pharmacol 57:11-17.
54. O'Donnell EP, Zerbe LK, Dwyer-Nield LD, Kisley LR, Malkinson AM. 2006. Quantitative analysis of early chemically-induced pulmonary lesions in mice of varying susceptibilities to lung tumorigenesis. Cancer Lett 241:197-202.
55. Phillips JM, Goodman JI. 2009. Inhalation of cigarette smoke induces regions of altered DNA methylation (RAMs) in SENCAR mouse lung. Toxicology 260:7-15.
56. Pritchard JB, French JE, Davis BJ, Haseman JK. 2003. Te role of transgenic mouse models in carcinogen identifcation. Environ Health Perspect 111:444-454.
57. Sheldon WG, Bucci TJ, Hart RW, Turturro A. 1995. Age-related neoplasia in a lifetime study of ad libitum-fed and food-restricted B6C3F1 mice. Toxicol Pathol 23:458-476.
58. Stinn W, Teredesai A, Anskeit E, Rustemeier K, Schepers G, Schnell P, Haussmann HJ, Carchman RA, Coggins CR, Reininghaus W. 2005a. Chronic nose-only inhalation study in rats, comparing room-aged sidestream ciga-rette smoke and diesel engine exhaust. Inhal Toxicol 17:549-576.
59. Stinn W, Teredesai A, Kuhl P, Knörr-Wittmann C, Kindt R, Coggins C, Haussmann HJ. 2005b. Mechanisms involved in A/J mouse lung tumori-genesis induced by inhalation of an environmental tobacco smoke sur-rogate. Inhal Toxicol 17:263-276.
60. Takahashi H, Ogata H, Nishigaki R, Broide DH, Karin M. 2010. Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta-and JNK1-dependent infammation. Cancer Cell 17:89-97.
61. Wakamatsu N, Devereux TR, Hong HH, Sills RC. 2007. Overview of the molecular carcinogenesis of mouse lung tumor models of human lung cancer. Toxicol Pathol 35:75-80.
62. Wang Y, Zhang Z, Lubet R, You M. 2005. Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/ Arf. Oncogene 24:3042-3049.
63. Weed DL. 2002. Environmental epidemiology: basics and proof of cause-efect. Toxicology 181-182:399-403.
64. Wells MY, Williams ES. 2009. Te transgenic mouse assay as an alternative test method for regulatory carcinogenicity studies-implications for REACH. Regul Toxicol Pharmacol 53:150-155.
65. Witschi H. 2005. A/J mouse as a model for lung tumorigenesis caused by tobacco smoke: strengths and weaknesses. Exp Lung Res 31:3-18.
66. Witschi H. 2007. Tobacco smoke-induced lung cancer in animals-a challenge to toxicology. Int J Toxicol 26:339-344.
67. Witschi H, Espiritu I, Maronpot RR. 2006. Lung tumors in 2 year old strain A/J mice exposed for 6 months to tobacco smoke. Cancer Lett 241:64-68.
68. Yamamoto S, Urano K, Koizumi H, Wakana S, Hioki K, Mitsumori K, Kurokawa Y, Hayashi Y, Nomura T 1998. Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Environ Health Perspect 106 Suppl 1:57-69. (Pubitemid 28196036)
69. Yan Y, Tan Q, Wang Y, Wang D, Jin M, Gordon T, Lubet RA, You M. 2007. Enhanced lung tumor development in tobacco smoke-exposed p53 transgenic and Kras2 heterozygous defcient mice. Inhal Toxicol 19 Suppl 1:183-187.
70. Yao R, Wang Y, D'Agostini F, Izzotti A, Lubet RA, You M, De Flora S. 2005. K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke. Exp Lung Res 31:271-281.
71. Zhang S, Xu N, Nie J, Dong L, Li J, Tong J. 2008. Proteomic alteration in lung tissue of rats exposed to cigarette smoke. Toxicol Lett 178:191-196.
72. Zhang Z, Liu Q, Lantry LE, Wang Y, Kellof GJ, Anderson MW, Wiseman RW, Lubet RA, You M. 2000. A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efcacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res 60:901-907.
73. Zhong CY, Zhou YM, Douglas GC, Witschi H, Pinkerton KE. 2005. MAPK/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats. Carcinogenesis 26:2187-2195.
74. Zhong CY, Zhou YM, Pinkerton KE. 2008. NF-kappaB inhibition is involved in tobacco smoke-induced apoptosis in the lungs of rats. Toxicol Appl Pharmacol 230:150-158.